A series of studies have been conducted by experimental and theoretical methods on the synthesis, structures, and reactions of CpRh boryl complexes that are likely intermediates in the rhodium-catalyzed regioselective, terminal functionalization of alkanes. The photochemical reaction of CpRh(eta(6)-C(6)Me(6)) with pinacolborane (HBpin) generates the bisboryl complex CpRh(H)(2)(Bpin)(2) (2), which reacts with neat HBpin to generate CpRh(H)(Bpin)(3) (3). X-ray diffraction, density functional theory (DFT) calculations, and NMR spectroscopy suggest a weak, but measurable, B-H bonding interaction. Both 2 and 3 dissociate HBpin and coordinate PEt(3) or P(p-Tol)(3) to generate the conventional rhodium(III) species CpRh(PEt(3))(H)(Bpin) (4) and CpRh[P(p-tol)(3)](Bpin)(2) (5). Compounds 2 and 3 also react with alkanes and arenes to form alkyl- and arylboronate esters at temperatures similar to or below those of the catalytic borylation of alkanes and arenes. Further, these compounds were observed directly in catalytic reactions. The enthalpies and free energies for generation of the 16-electron intermediate and for the C-H bond cleavage and B-C bond formation have been calculated with DFT. These results strongly suggest that the C-H bond cleavage process occurs by a metal-assisted sigma-bond metathesis mechanism to generate a borane complex that isomerizes if necessary to place the alkyl group cis to the boryl group. This complex with cis boryl and alkyl groups then undergoes B-C bond formation by a second sigma-bond metathesis to generate the final functionalized product.
A combined experimental/quantum chemical investigation of the transition metal-mediated dehydrocoupling reaction of H(3)B.NMe(2)H to ultimately give the cyclic dimer [H(2)BNMe(2)](2) is reported. Intermediates and model complexes have been isolated, including examples of amine-borane sigma-complexes of Rh(I) and Rh(III). These come from addition of a suitable amine-borane to the crystallographically characterized precursor [Rh(eta(6)-1,2-F(2)C(6)H(4))(P(i)Bu(3))(2)][BAr(F)(4)] [Ar(F) = 3,5-(CF(3))(2)C(6)H(3)]. The complexes [Rh(eta(2)-H(3)B.NMe(3))(P(i)Bu(3))(2)][BAr(F)(4)] and [Rh(H)(2)(eta(2)-H(3)B.NHMe(2))(P(i)Bu(3))(2)][BAr(F)(4)] have also been crystallographically characterized. Other intermediates that stem from either H(2) loss or gain have been characterized in solution by NMR spectroscopy and ESI-MS. These complexes are competent in the catalytic dehydrocoupling (5 mol %) of H(3)B.NMe(2)H. During catalysis the linear dimer amine-borane H(3)B.NMe(2)BH(2).NHMe(2) is observed which follows a characteristic intermediate time/concentration profile. The corresponding amine-borane sigma-complex, [Rh(P(i)Bu(3))(2)(eta(2)-H(3)B.NMe(2)BH(2).NHMe(2))][BAr(F)(4)], has been isolated and crystallographically characterized. A Rh(I) complex of the final product, [Rh(P(i)Bu(3))(2){eta(2)-(H(2)BNMe(2))(2)}][BAr(F)(4)], is also reported, although this complex lies outside the proposed catalytic cycle. DFT calculations show that the first proposed dehydrogenation step, to give H(2)B horizontal lineNMe(2), proceeds via two possible routes of essentially the same energy barrier: BH or NH activation followed by NH or BH activation, respectively. Subsequent to this, two possible low energy routes that invoke either H(2)/H(2)B horizontal lineNMe(2) loss or H(2)B horizontal lineNMe(2)/H(2) loss are suggested. For the second dehydrogenation step, which ultimately affords [H(2)BNMe(2)](2), a number of experimental observations suggest that a simple intramolecular route is not operating: (i) the isolated complex [Rh(P(i)Bu(3))(2)(eta(2)-H(3)B.NMe(2)BH(2).NHMe(2))][BAr(F)(4)] is stable in the absence of amine-boranes; (ii) addition of H(3)B.NMe(2)BH(2).NHMe(2) to [Rh(P(i)Bu(3))(2)(eta(2)-H(3)B.NMe(2)BH(2).NHMe(2))][BAr(F)(4)] initiates dehydrocoupling; and (iii) H(2)B horizontal lineNMe(2) is also observed during this process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.